Weekly CEO Buys: Ryman Hospitality, OPKO Health, Actuant Corp.

Recent insider buys from company CEOs

Author's Avatar
Jul 18, 2016
Article's Main Image

According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below:

Ryman Hospitality Properties Inc.: Chairman and CEO Colin V. Reed bought 7,377 shares

Reed bought 7,377 shares on July 15, 2016 at a price of $53.44.

Ryman Hospitality operates as real estate investment trust specializing in group-oriented, destination hotel assets in urban and resort markets. Ryman Hospitality has a market cap of $2.71 billion; as of July 15, its shares traded at $53.78 with a P/E ratio of 20.84.

The price of the stock has increased by 0.64% since Reed bought the stock.

OPKO Health Inc.: CEO, Chairman and 10% owner Phillip Frost bought 25,800 shares

Frost bought 25,800 shares during the past week at a price of $9.72.

OPKO Health was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. The company is a multi-national biopharmaceutical and diagnostics company. OPKO Health has a market cap of $5.45 billion; as of July 15, its shares were traded at $9.95 with a P/E ratio of 68.15.

Consolidated revenues for the first fiscal quarter ended March 31 increased to $291.0 million from $30.1 million in the year-ago quarter. Net loss for the first quarter was $12.0 million compared with net loss of $117.1 milion for the 2015 period.

Frost bought 21,000 shares of OPK stock on June 27 at a price of $8.88 per share and 12,800 shares on June 29 at a price of $9.24 per share. The price of the stock has increased by 3.11% since.

Actuant Corp.: President and CEO Randal W. Baker bought 10,795 shares

Baker bought 10,795 shares on July 11 at a price of $23.14.

Actuant was incorporated in 1910 as a Wisconsin corporation. It is a diversified company that designs, manufactures and distributes various industrial products and systems. Actuant has a market cap of $1.42 billion; as of July 15, its shares traded at $24.08.

Consolidated sales for the third quarter were $305 million, 5% lower than the $320 million in the comparable prior year quarter. Fiscal 2016 third quarter net earnings were $21.2 million, or 36 cents per share compared to $38.0 million or 63 cents per share in the comparable prior year period.

The price of the stock has increased by 4.06% since Baker bought the stock.

For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.